
Surgery Partners Inc
NASDAQ:SGRY

Intrinsic Value
The intrinsic value of one
SGRY
stock under the Base Case scenario is
40.9
USD.
Compared to the current market price of 23.32 USD,
Surgery Partners Inc
is
Undervalued by 43%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Surgery Partners Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Surgery Partners Inc
Balance Sheet Decomposition
Surgery Partners Inc
Current Assets | 1.1B |
Cash & Short-Term Investments | 229.3m |
Receivables | 570.6m |
Other Current Assets | 274.7m |
Non-Current Assets | 6.9B |
Long-Term Investments | 218.6m |
PP&E | 1.4B |
Intangibles | 5.2B |
Other Non-Current Assets | 55.8m |
Free Cash Flow Analysis
Surgery Partners Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Surgery Partners Inc
Revenue
|
3.2B
USD
|
Cost of Revenue
|
-2.3B
USD
|
Gross Profit
|
841.1m
USD
|
Operating Expenses
|
-367.6m
USD
|
Operating Income
|
473.5m
USD
|
Other Expenses
|
-666.9m
USD
|
Net Income
|
-193.4m
USD
|
SGRY Profitability Score
Profitability Due Diligence
Surgery Partners Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Score
Surgery Partners Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
SGRY Solvency Score
Solvency Due Diligence
Surgery Partners Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Score
Surgery Partners Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SGRY Price Targets Summary
Surgery Partners Inc
According to Wall Street analysts, the average 1-year price target for
SGRY
is 32.66 USD
with a low forecast of 24.24 USD and a high forecast of 37.8 USD.
Dividends
Current shareholder yield for SGRY is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SGRY
stock under the Base Case scenario is
40.9
USD.
Compared to the current market price of 23.32 USD,
Surgery Partners Inc
is
Undervalued by 43%.